Antiobesity effects of the ethanol extract of Laminaria japonica Areshoung in high-fat-diet-induced obese rat

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Jang, Woong Sun ^a   Choung, Se Young ^a  

^a Kyung Hee University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANTIOBESITY AGENT; FAT DROPLET; LAMINARIA JAPONICA ARESHOUNG ETHANOL EXTRACT; PLANT EXTRACT; UNCLASSIFIED DRUG;

ADIPOCYTE; ANIMAL EXPERIMENT; ARTICLE; CELL SIZE; CONTROLLED STUDY; DRUG MECHANISM; FATTY ACID OXIDATION; FATTY ACID SYNTHESIS; HISTOLOGY; LAMINARIA JAPONICA; LIPID DIET; MALE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; THERMOGENESIS; WEIGHT REDUCTION;

EID: 84873333997     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/492807     Document Type: Article

References (65)

1. Devlin M. J., Yanovski S. Z., Wilson G. T., Obesity: what mental health professionals need to know. American Journal of Psychiatry 2000 157 6 854 866 2-s2.0-0034047295 10.1176/appi.ajp.157.6.854 (Pubitemid 30412334)
2. Fujioka K., Management of obesity as a chronic disease: nonpharmacologic, pharmacologic, and surgical options. Obesity Research 2002 10 2 116 123 2-s2.0-1842521023
3. Rich B. S., Keel R., Ho V. P., Turbendian H., Cefepime dosing in the morbidly obese patient population. Obesity Surgery 2012 22 465 471
4. Unger R. H., Lipid overload and overflow: metabolic trauma and the metabolic syndrome. Trends in Endocrinology and Metabolism 2003 14 9 398 403 2-s2.0-0242696221 10.1016/j.tem.2003.09.008 (Pubitemid 37392211)
5. Stunkard A. J., Allison K. C., Binge eating disorder: disorder or marker? International Journal of Eating Disorders 2003 34 S107 S116 2-s2.0-0042490724 10.1002/eat.10210 (Pubitemid 36935718)
6. Stunkard A. J., Allison K. C., Two forms of disordered eating in obesity: binge eating and night eating. International Journal of Obesity 2003 27 1 1 12 2-s2.0-0037255255 10.1038/sj.ijo.0802186 (Pubitemid 36152773)
7. Stunkard A. J., Faith M. S., Allison K. C., Depression and obesity. Biol Psychiatry 2003 54 330 337 (Pubitemid 37270615)
8. Kopolman P. G., Obesity as a medical problem. Nature 2000 404 635 643
9. Hofbauer K. G., Nicholson J. R., Boss O., The obesity epidemic: current and future pharmacological treatments. Annual Review of Pharmacology and Toxicology 2007 47 565 592
10. Kishino E., Ito T., Fujita K., Kiuchi Y., A mixture of the Salacia reticulata (Kotala himbutu) aqueous extract and cyclodextrin reduces the accumulation of visceral fat mass in mice and rats with high-fat diet-induced obesity. Journal of Nutrition 2006 136 2 433 439 2-s2.0-32444444064 (Pubitemid 43228298)
11. Mayer M. A., Hocht C., Puyo A., Taira C. A., Recent advances in obesity pharmacotherapy. Current Clinical Pharmacology 2009 4 53 61
12. Nakayama T., Suzuki S., Kudo H., Sassa S., Nomura M., Sakamoto S., Effects of three Chinese herbal medicines on plasma and liver lipids in mice fed a high-fat diet. Journal of Ethnopharmacology 2007 109 2 236 240 2-s2.0-33845663993 10.1016/j.jep.2006.07.041 (Pubitemid 44959697)
13. Park M. Y., Lee K. S., Sung M. K., Effects of dietary mulberry, Korean red ginseng, and banaba on glucose homeostasis in relation to PPAR- α PPAR- γ and LPL mRNA expressions. Life Sciences 2005 77 26 3344 3354 2-s2.0-26444562863 10.1016/j.lfs.2005.05.043 (Pubitemid 41434077)
14. Han L. K., Kimura Y., Okuda H., Anti-obesity effects of natural products. Studies in Natural Products Chemistry 2005 30 79 110
15. Moro C. O., Basile G., Obesity and medicinal plants. Fitoterapia 2000 71 73 82
16. Rayalam S., Della-Fera M. A., Baile C. A., Phytochemicals and regulation of the adipocyte life cycle. Journal of Nutritional Biochemistry 2008 19 11 717 726 2-s2.0-53149091637 10.1016/j.jnutbio.2007.12.007
17. Thielecke F., Boschmann M., The potential role of green tea catechins in the prevention of the metabolic syndrome-a review. Phytochemistry 2009 70 1 11 24 2-s2.0-59049095317 10.1016/j.phytochem.2008.11.011
18. Marx J., Cellular warriors at the battle of the bulge. Science 2003 299 5608 846 849 2-s2.0-0037423143 10.1126/science.299.5608.846 (Pubitemid 36182432)
19. Kang J. Y., Anti-inflammatory activities of Undariapinnatifida and Laminaria japonica (Phaeophyta) [M.S. thesis] 2008 Busan, South Korea Graduate School of Pukyong National University
20. Zhou Q. F., Li M. Y., Na G. S., Li C. W., Progress in research of anti-tumor mechanisms of marine polysaccharides. Chinese Pharmacological Bulletin 2009 25 995 997
21. Xu X. Y., Shuai L., Guo Y. L., Duan D. L., Regulating effects and mechanism of Laminaria Japonica on serum lipid of hyperlipidemia in rats Chin. Journal of Marine Drugs 2009 28 1 4
22. Shuai L., Xu X. Y., Guo Y. L., Duan D. L., Study on the antioxidant effects of Laminaria japonica in hyperlipemia rats. Chinese Journal of Marine Drugs 2010 29 1 4
23. Imbs T. I., Krasovskaya N. P., Ermakova S. P., Makarieva T. N., Shevchenko N. M., Zvyagintseva T. N., Comparative study of chemical composition and antitumor activity of aqueous-ethanol extracts of brown algae Laminaria cichorioides, Costaria costata, and Fucus evanescens. Russian Journal of Marine Biology 2009 35 2 164 170 2-s2.0-65649147234 10.1134/S1063074009020084
24. Samee H., Li Z. X., Lin H., Khalid J., Guo Y. C., Anti-allergic effects of ethanol extracts from brown seaweeds. Journal of Zhejiang University B 2009 10 2 147 153 2-s2.0-62249162235 10.1631/jzus.B0820185
25. Choo J. J., Green tea reduces body fat accretion caused by high-fat diet in rats through β -adrenoceptor activation of thermogenesis in brown adipose tissue. Journal of Nutritional Biochemistry 2003 14 11 671 676 2-s2.0-0242642853 10.1016/j.jnutbio.2003.08.005 (Pubitemid 37415270)
26. Klaus S., Pultz S., Thone-Reineke C., Wolfram S., Epigallocatechin gallate attenuates diet-induced obesity in mice by decreasing energy absorption and increasing fat oxidation. International Journal of Obesity 2005 29 615 623 (Pubitemid 40769483)
27. Yamabe N., Yokozawa T., Oya T., Kim M., Therapeutic potential of (-)-epigallocatechin 3-O-gallate on renal damage in diabetic nephropathy model rats. Journal of Pharmacology and Experimental Therapeutics 2006 319 1 228 236 2-s2.0-33749011205 10.1124/jpet.106.107029 (Pubitemid 44455127)
28. Chyu K. Y., Babbidge S. M., Rietveld A. G., Shah P. K., Differential effects of green tea-derived catechin on developing versus established atherosclerosis in apolipoprotein E-null mice. Circulation 2004 109 20 2448 2453 2-s2.0-2542446098 10.1161/01.CIR.0000128034.70732.C2 (Pubitemid 38679566)
29. Babu P. V. A., Sabitha K. E., Shyamaladevi C. S., Therapeutic effect of green tea extract on oxidative stress in aorta and heart of streptozotocin diabetic rats. Chemico-Biological Interactions 2006 162 2 114 120 2-s2.0-33746897678 10.1016/j.cbi.2006.04.009 (Pubitemid 44189959)
30. Friedewald W. T., Levy R. I., Fredrickson D. S., Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical Chemistry 1972 18 6 499 502 2-s2.0-0015348189
31. Folch J., Lees M., Sloane Stanley G. H., A simple method for the isolation and purification of total lipides from animal tissues. The Journal of Biological Chemistry 1957 226 1 497 509 2-s2.0-70449158340
32. Madsen A. N., Hansen G., Paulsen S. J., Lykkegaard K., Tang-Christensen M., Hansen H. S., Levin B. E., Larsen P. J., Knudsen L. B., Fosgerau K., Vrang N., Long-term characterization of the diet-induced obese and diet-resistant rat model: a polygenetic rat model mimicking the human obesity syndrome. Journal of Endocrinology 2010 206 3 287 296 2-s2.0-77955612057 10.1677/JOE-10-0004
33. Morishita S., Saito T., Mishima Y., Mizutani A., Hirai Y., Koyama S., Kawakami M., Strains and species differences in experimental hyperlipidemia. Nippon Yakurigaku Zasshi 1986 87 259 264 (Pubitemid 16160231)
34. Friedman J. M., Halaas J. L., Leptin and the regulation of body weight in mammals. Nature 1998 395 6704 763 770 2-s2.0-0032558725 10.1038/27376 (Pubitemid 28485436)
35. Staiger H., Haring H. U., Adipocytokines: fat-derived humoral mediators of metabolic homeostasis. Experimental and Clinical Endocrinology & Diabetes 2005 113 37 79
36. Uygun A., Kadayifci A., Yesilova Z., Erdil A., Yaman H., Saka M., Deveci M. S., Bagci S., Gulsen M., Karaeren N., Dagalp K., Serum leptin levels in patients with nonalcoholic steatohepatitis. American Journal of Gastroenterology 2000 95 12 3584 3589 2-s2.0-0033636915 10.1016/S0002-9270(00)02090-6
37. Gauthier M. S., Couturier K., Latour J. G., Lavoie J. M., Concurrent exercise prevents high-fat-diet-induced macro vesicular hepatic steatosis. Journal of Applied Physiology 2003 94 2127 2134 (Pubitemid 36605269)
38. Fasshauer M., Klein J., Krahlisch S., Lössner U., Klier M., Blüher M., Paschke R., GH is a positive regulator of tumor necrosis factor α -induced adipose related protein in 3T3-L1 adipocytes. Journal of Endocrinology 2003 178 3 523 531 2-s2.0-0141731235 10.1677/joe.0.1780523 (Pubitemid 37220178)
39. Hotamisligil G. S., Spiegelman B. M., Tumor necrosis factor α: a key component of the obesity-diabetes link. Diabetes 1994 43 11 1271 1278 2-s2.0-0028587742
40. Hotamisligil G. S., Mechanisms of TNF-alpha-induced insulin resistance. Experimental and Clinical Endocrinology & Diabetes 1999 107 119 125
41. Haiyan X. U., Hirosumi J., Uysal K. T., Guler A. D., Hotamisligil G. S., Exclusive action of transmembrane TNF α in adipose tissue leads to reduced adipose mass and local but not systemic insulin resistance. Endocrinology 2002 143 4 1502 1511 2-s2.0-0036212593 10.1210/en.143.4.1502 (Pubitemid 34274381)
42. Hotamisligil G. S., Arner P., Caro J. F., Atkinson R. L., Spiegelman B. M., Increased adipose tissue expression of tumor necrosis factor- α in human obesity and insulin resistance. Journal of Clinical Investigation 1995 95 5 2409 2415 2-s2.0-0028931724
43. Tanaka T., Yamamoto J., Iwasaki S., Activation of peroxisome proliferator-activated receptor δ induces fatty acid β-oxidation in skeletal muscle and attenuates metabolic syndrome. Proceedings of the National Academy of Sciences 2003 100 15924 15929 (Pubitemid 38021091)
44. Wang Y. X., Zhang C. L., Yu R. T., Regulation of muscle fiber type and running endurance by PPAR δ PLoS Biology 2004 2, article 294
45. Villarroya F., Iglesias R., Giralt M., PPARs in the control of uncoupling proteins gene expression. PPAR Research 2007 2007 12 2-s2.0-42749100308 10.1155/2007/74364 74364
46. Myeong J. Y., Gha Y. L., Chung J. J., Young H. A., Seung H. H., Jae B. K., Adiponectin increases fatty acid oxidation in skeletal muscle cells by sequential activation of AMP-activated protein kinase, p38 mitogen-activated protein kinase, and peroxisome proliferator-activated receptor{alpha}. Diabetes 2006 55 9 2562 2570 2-s2.0-33750578279 10.2337/db05-1322 (Pubitemid 44871157)
47. Park J., Rho H. K., Kim K. H., Choe S. S., Lee Y. S., Kim J. B., Overexpression of glucose-6-phosphate dehydrogenase is associated with lipid dysregulation and insulin resistance in obesity. Molecular and Cellular Biology 2005 25 12 5146 5157 2-s2.0-20344373410 10.1128/MCB.25.12.5146-5157.2005 (Pubitemid 40781113)
48. Rosen E. D., Walkey C. J., Puigserver P., Spiegelman B. M., Transcriptional regulation of adipogenesis. Genes and Development 2000 14 11 1293 1307 2-s2.0-0034214246 (Pubitemid 30397073)
49. Locke G. A., Cheng D., Witmer M. R., Tamura J. K., Haque T., Carney R. F., Rendina A. R., Marcinkeviciene J., Differential activation of recombinant human acetyl-CoA carboxylases 1 and 2 by citrate. Archives of Biochemistry and Biophysics 2008 475 1 72 79 2-s2.0-49949152610 10.1016/j.abb.2008.04.011
50. Agarwal A. K., Garg A., Congenital generalized lipodystrophy: significance of triglyceride biosynthetic pathways. Trends in Endocrinology and Metabolism 2003 14 5 214 221 2-s2.0-0038607416 10.1016/S1043-2760(03)00078-X (Pubitemid 36841479)
51. Coleman R. A., Lee D. P., Enzymes of triacylglycerol synthesis and their regulation. Progress in Lipid Research 2004 43 134 176 (Pubitemid 37492937)
52. Gonzalez-Baró M. R., Lewin T. M., Coleman R. A., Regulation of Triglyceride Metabolism II. Function of mitochondrial GPAT1 in the regulation of triacylglycerol biosynthesis and insulin action. American Journal of Physiology 2007 292 5 G1195 G1199 2-s2.0-34347402636 10.1152/ajpgi.00553.2006 (Pubitemid 47084642)
53. Shi Y., Cheng D., Beyond triglyceride synthesis: The dynamic functional roles of MGAT and DGAT enzymes in energy metabolism. American Journal of Physiology 2009 297 1 E10 E18 2-s2.0-67650096808 10.1152/ajpendo.90949.2008
54. Turkish A., Sturley S. L., Regulation of Triglyceride Metabolism. I. Eukaryotic neutral lipid synthesis: "Many ways to skin ACAT or a DGAT" American Journal of Physiology 2007 292 953 957
55. Yen C. L. E., Stone S. J., Koliwad S., Harris C., Farese R. V., DGAT enzymes and triacylglycerol biosynthesis. Journal of Lipid Research 2008 49 11 2283 2301 2-s2.0-58149457426 10.1194/jlr.R800018-JLR200
56. Inoue M., Ohtake T., Motomura W., Takahashi N., Hosoki Y., Miyoshi S., Suzuki Y., Saito H., Kohgo Y., Okumura T., Increased expression of PPAR γ in high fat diet-induced liver steatosis in mice. Biochemical and Biophysical Research Communications 2005 336 1 215 222 2-s2.0-24344468717 10.1016/j.bbrc.2005.08.070 (Pubitemid 41253423)
57. Tanaka T., Masuzaki H., Ebihara K., Ogawa Y., Yasue S., Yukioka H., Chusho H., Miyanaga F., Miyazawa T., Fujimoto M., Kusakabe T., Kobayashi N., Hayashi T., Hosoda K., Nakao K., Transgenic expression of mutant peroxisome proliferator-activated receptor γ in liver precipitates fasting-induced steatosis but protects against high-fat diet-induced steatosis in mice. Metabolism 2005 54 11 1490 1498 2-s2.0-27344454809 10.1016/j.metabol.2005.05.015 (Pubitemid 41527019)
58. Kim J. K., Fillmore J. J., Chen Y., Yu C., Moore I. K., Pypaert M., Lutz E. P., Kako Y., Velez-Carrasco W., Goldberg I. J., Breslow J. L., Shulman G. I., Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance. Proceedings of the National Academy of Sciences of the United States of America 2001 98 13 7522 7527 2-s2.0-0035912744 10.1073/pnas.121164498 (Pubitemid 32567981)
59. Yamauchi T., Kamon J., Minokoshi Y., Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nature Medicine 2002 8 1288 1295 (Pubitemid 35373562)
60. Minokoshi Y., Kim Y. B., Peroni O. D., Fryer L. G. D., Müller C., Carling D., Kahn B. B., Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 2002 415 6869 339 343 2-s2.0-0037122766 10.1038/415339a (Pubitemid 34087557)
61. Hardie D. G., AMPK: a key regulator of energy balance in the single cell and the whole organism. International Journal of Obesity 2008 32 7 12
62. Park H., Kaushik V. K., Constant S., Prentki M., Przybytkowski E., Ruderman N., Saha A. K., Coordinate regulation of malonyl-CoA decarboxylase, sn-glycerol-3-phosphate acyltransferase, and acetyl-CoA carboxylase by AMP-activated protein kinase in rat tissues in response to exercise. Journal of Biological Chemistry 2002 277 36 32571 32577 2-s2.0-0037031840 10.1074/jbc.M201692200 (Pubitemid 34984761)
63. Winder W. W., Hardie D. G., AMP-activated proteinkinase, a metabolic master switch: possible roles in type 2 diabetes. American Journal of Physiology 1999 277 1 10
64. Ruderman N. B., Saha A. K., Vavvas D., Witters L. A., Malonyl-CoA, fuel sensing and insulin resistance. American Journal of Physiology 1999 276 1 18
65. McGarry J. D., Brown N. F., The mitochondrial carnitine palmitoyltransferase system: from concept to molecular analysis. European Journal of Biochemistry 1997 244 1 1 14 2-s2.0-0031043030 (Pubitemid 27079689)